CompletedPhase 2/3

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

Egypt68 participantsStarted 2022-11-10

Plain-language summary

The aim of the current study is to compare the effect of intranasal versus nebulized route of administration of midazolam as moderate sedative agents in preschoolers undergoing dental treatment.

Who can participate

Age range3 Years – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Frankl scale score 2. * ASA I or II physical status. * Dental intervention under local anesthesia not requiring more than 30 minutes. * No previous dental experience. * Parent/guardian's written consent. Exclusion Criteria: * Dental treatment indicated under general anesthesia. * Presence of facial or nasal deformities. * History of neurological or cognitive alterations. * Mouth breathers

What they're measuring

Behavior rating

Timeframe: throughout the sedation session

Trial details

NCT IDNCT05883150

SponsorNourhan M.Aly

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-30

View on ClinicalTrials.gov More Dental Sedation trials